Ziekenhuisgroep Twente Stichting

At Ziekenhuisgroep Twente Stichting in Almelo, a major share of research focuses on neoplasms and advanced cancer care, especially breast cancer, prostate cancer, non-small cell lung cancer, colorectal cancer, and gastroesophageal cancers. These studies are designed to improve treatment effectiveness, refine care strategies, and test new combinations or sequencing of cancer therapies.

• Evaluating new treatment approaches for metastatic and locally advanced cancers
• Improving outcomes in HER2-positive, hormone receptor-positive, and triple negative breast cancer
• Testing targeted therapies and immunotherapy-based strategies in solid tumors and blood cancers
• Studying ways to optimize survival, disease control, and tolerability in oncology care

The site’s Internal Oncology department contributes to a broad portfolio of cancer trials, including research on tumor-specific diagnostics and treatment personalization.

Clinical research also covers hemic and lymphatic diseases, with studies in diffuse large B-cell lymphoma, multiple myeloma, non-Hodgkin lymphoma, and T-cell prolymphocytic leukemia. The main goal is to improve treatment benefit while reducing toxicity and long-term complications.

• Assessing better treatment strategies for lymphoma and myeloma
• Studying prevention of treatment-related heart damage in blood cancer care
• Exploring personalized targeted therapy for hematologic malignancies
• Measuring how therapy choices affect disease control and safety

This research reflects a strong interest in balancing effectiveness with quality of life for patients with complex blood cancers.

Another important research area includes cardiovascular diseases, chronic kidney disease, and nutritional and metabolic diseases, with studies in atherosclerotic cardiovascular disease, heart failure prevention, albuminuria, type 2 diabetes, and obesity. These trials aim to reduce major health events and improve long-term organ protection.

• Testing therapies to lower cardiovascular risk in high-risk patients
• Studying treatments that reduce kidney damage and albuminuria
• Evaluating approaches for patients with diabetes, obesity, and related complications
• Looking at ways to prevent heart failure and kidney failure

The research portfolio shows a clear focus on chronic disease management and prevention across interconnected heart, kidney, and metabolic conditions.

The site also investigates digestive system diseases, respiratory tract diseases, and selected pathological conditions, including gastric cancer, appendicitis, post-surgical neuropathic pain, acute respiratory tract infection, and pneumonia. These studies often focus on improving recovery, staging, and treatment outcomes in hospital-based care.

• Evaluating surgical and supportive approaches to reduce complications
• Improving diagnosis and staging in advanced gastric cancer
• Testing strategies to support recovery in respiratory infections and pneumonia
• Assessing pain relief and complication prevention after surgery

Research in these fields combines practical hospital care questions with efforts to improve patient comfort, safety, and clinical decision-making.

Several trials at Ziekenhuisgroep Twente Stichting explore diagnostic and therapeutic techniques, including imaging-based selection tools, biomarker-guided treatment, and personalized therapy matching. The diseases studied range from prostate cancer and gastric cancer to breast cancer and advanced solid tumors.

• Using imaging and biomarker tools to improve treatment selection
• Personalizing cancer therapy based on tumor characteristics
• Studying whether diagnostic advances can reduce unnecessary procedures
• Supporting more tailored and efficient care pathways

This work highlights a strong interest in precision medicine, with research aimed at making treatment choices more effective and better matched to each patient.